Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Health Care · ·
$1.93
▲ $0.02 (+1.0%)
Market data updated: 09/22 01:50 AM
Fundamentals updated: 09/22/2026
News analyzed: 09/22/2026
Market Cap
$215.50M
Day Range
$1.85 - $1.95
52-Week Range
$1.09 - $3.40
Beta
—
Next Earnings
04.11.2026
Support
$1.37
Resistance
$2.76
ALEC is a stock from the Healthcare sector — Pharmaceuticals, biotech, medical devices, and health insurance — less sensitive to economic cycles, but exposed to regulation and FDA approvals.
-36.3% (1Y)
Strengths: 9/30 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🔴 Bearish
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Free cash flow growth
Free cash flow growth: 20.4%
Growth
Biggest negative driver
Operating margin
Operating margin: -741.3% (negative)
Fundamental
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 3 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 3
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
41
Today
—
30D
—
90D
—
1Y
🕰️ Signal Timeline
What StockIQ actually saw for this stock, and what happened after each signal — real data, not a forecast.
1d ago · $1.91
Evidence: Panic-selling score jumped from 4 to 36 day-over-day
What happened after
Still awaiting outcome
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
Not enough data yet to generate this synthesis.
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
40
Quality
63
Value
50
Momentum
25
Risk
46
Sentiment
56
Fundamental
34
Institutional
0
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Everyone's writing about Alector, Inc.. News trend score: 56. Reason: 1 of the last 9 articles are positive, versus 0 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
28
🎯 Conviction (vs. Emotion)
26
Psychology
35
Fundamentals
34
Technical
25
Valuation
50
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Price, sentiment, and valuation keep confirming each other upward while the actual fundamentals deteriorate.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price (3M)
+5%
Market Narrative
35
Fundamental Reality
26
Narrative Gap
+9
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 Market Brain events driving this
📈 4D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Charles Mackay — 97/100
🔴 Weakest match
Jesse Livermore — 29/100
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 97
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟢 97
Strong liquidity — would likely survive a real credit squeeze
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 90
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 71
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 65
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 59
Mixed — doesn't clearly pass Graham's tests
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟡 59
Moderate — holdable, but not effortless
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 56
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 51
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 47
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 45
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 44
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 39
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 37
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 32
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 29
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Based on the last 282 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (2 bullish · 9 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Low confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
-741.3%
Net Margin
-679.2%
EBITDA Margin
-714.1%
ROE
-466.3%
ROA
-48.7%
ROIC
—
EPS
-$1.39
Cash
$65.80M
Total Debt
$9.69M
Current Ratio
3.83
Debt/Equity
0.32
How is Fair Value calculated? →
Current Price
$1.93
Estimated Fair Value (DCF)
-$23.07
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
⚠️ Extreme
Model output is extreme — likely a data/model limitation for this stock, not a reliable fair-value read.
Year 1 Growth Rate
-5.0%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | -5.0% | $-174.87M | $-160.43M |
| 2 | -3.1% | $-169.40M | $-142.58M |
| 3 | -1.2% | $-167.29M | $-129.18M |
| 4 | 0.6% | $-168.33M | $-119.25M |
| 5 | 2.5% | $-172.54M | $-112.14M |
Base FCF (last actual year)
$-184.07M
Terminal Value
$-2.72B
Present Value of Terminal Value
$-1.77B
Enterprise Value
$-2.43B
Net Debt
$-56.11M
Equity Value
$-2.38B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$0.30
Tangible Book Value per Share (Tangible NAV)
$0.30
Sentiment based on basic keywords (not AI) — 1 positive, 8 neutral, 0 negative out of the last 9 articles.
SeekingAlpha · 15.9.2026
SeekingAlpha · 15.9.2026
GlobeNewswire · 3.9.2026
Yahoo · 3.9.2026
Zacks · 6.8.2026
Associated Press · 6.8.2026
GlobeNewswire · 6.8.2026
BioPharma Dive · 9.7.2026
Simply Wall St. · 19.6.2026
Alector, Inc. (ALEC) currently has a StockIQ AI score of 41/100, rated "Weak". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
ALEC currently scores 41/100 (Weak) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
ALEC's technical score is 25/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Free cash flow growth: 20.4%; Operating margin is stable or improving over time; Debt/equity: 0.32.
Based on the real signals StockIQ computed: Operating margin: -741.3% (negative); Net margin: -679.2% (negative); ATR: 9.7% of price.
StockIQ has no recorded dividend payment history for ALEC.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 5 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Wong-Sarad Grace | Open Market Sale | 4.9.2026 | 3,625 | -3,625 | $2.51 |
| Wong-Sarad Grace | Open Market Sale | 3.9.2026 | 5,165 | -5,165 | $2.67 |
| Rosenthal Arnon | Open Market Sale | 3.9.2026 | 72,606 | -72,606 | $2.66 |
| Berkley Neil Lindsay | Open Market Sale | 3.9.2026 | 29,251 | -29,251 | $2.66 |
| Wong-Sarad Grace | Open Market Sale | 2.9.2026 | 656 | -656 | $2.75 |
| Rosenthal Arnon | Gift | 19.8.2026 | 350,000 | +350,000 | — |
| Rosenthal Arnon | Gift | 19.8.2026 | 350,000 | +350,000 | — |
| Rosenthal Arnon | Gift | 19.8.2026 | 350,000 | +350,000 | — |
| Rosenthal Arnon | Gift | 19.8.2026 | 1,050,000 | -1,050,000 | — |
| Wong-Sarad Grace | Grant/Award from Employer | 9.7.2026 | 20,000 | +20,000 | — |
| Wong-Sarad Grace | Grant/Award from Employer | 9.7.2026 | 115,461 | +20,000 | — |
| LAVIGNE LOUIS J JR | Grant/Award from Employer | 17.6.2026 | 28,700 | +28,700 | — |
| DESOUZA ERROL B | Grant/Award from Employer | 17.6.2026 | 9,450 | +9,450 | — |
| GAROFALO ELIZABETH A. | Grant/Award from Employer | 17.6.2026 | 9,450 | +9,450 | — |
| Hammond Paula | Grant/Award from Employer | 17.6.2026 | 28,700 | +28,700 | — |
| Yaffe Kristine | Grant/Award from Employer | 17.6.2026 | 9,450 | +9,450 | — |
| DESOUZA ERROL B | Grant/Award from Employer | 17.6.2026 | 28,700 | +28,700 | — |
| GAROFALO ELIZABETH A. | Grant/Award from Employer | 17.6.2026 | 28,700 | +28,700 | — |
| Altmeyer Mark | Grant/Award from Employer | 17.6.2026 | 9,450 | +9,450 | — |
| LAVIGNE LOUIS J JR | Grant/Award from Employer | 17.6.2026 | 9,450 | +9,450 | — |
| SCHELLER RICHARD H | Grant/Award from Employer | 17.6.2026 | 28,700 | +28,700 | — |
| Yaffe Kristine | Grant/Award from Employer | 17.6.2026 | 28,700 | +28,700 | — |
| Altmeyer Mark | Grant/Award from Employer | 17.6.2026 | 28,700 | +28,700 | — |
| SCHELLER RICHARD H | Grant/Award from Employer | 17.6.2026 | 9,450 | +9,450 | — |
| Hammond Paula | Grant/Award from Employer | 17.6.2026 | 9,450 | +9,450 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
6,165,227 shares short as of 2026-08-31 · vs. 5,644,306 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
60.6% of trading volume this week was short selling, vs. 40.5% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology